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Thymus-derived lymphocytes (T cells) exert profound regulatory effects, both
positive and negative, on immunoglobulin (Ig) production (1) . Examples of negative
T cell regulation include suppressionofIg isotypes (2-4), allotypes (5-7), and idiotypes
(8-11) . With respect to allotype suppression in mice, two systems are of particular
interest . The first is concerned with mice derived from matings of BALB/c females
previously immunized with paternal IgG2a allotype (Igh-l b ), which fail to produce
Igh-lb (12) . In the second system, C.B-17 mice, an Ighb-positive strain with the
BALB/c background, fail to produce Igh-lb as a result of transferring lymphocytes
from BALB/c donors previously immunized with Igh-lb (7, 13) . The suppression in
both systems is chronic, mediated by T cells, can be adoptively transferred, and is
specific for Igh- lb .
Despite similarities in these two systems, two different mechanisms of allotype
suppression have been inferred . In the first, T cells are thought to suppress Igh-lb
production indirectly by eliminating a specific Igh-lb helper cell (6, 14), whereas in
the second system, T cells are presumed to suppress or eliminate Igh-lb-producing B
cells directly. Support for the latter mechanism comes from two observations : T cells
of mice immune to Igh-lb specifically suppress Igh-lb production in athymic nude
mice (15) and inhibit the growth of an Igh-lb-producing plasmacytoma (13) .
What is missing in both of the above systems is direct evidence bearing on the
specificity of the T cells in question . To investigate this point, we examined whether
BALB/c mice immune to Igh-lb contain Igh-lb-specific T cells . Two different func-
tional assays were used : (a) T cells were rosetted with Igh- lb- or Igh-la-coated
erythrocytes and tested for their ability to suppress Igh-lb production in vivo ; and (b)
T cells were tested for their ability to lyse various Ig-producing cell lines . Our results
indicate that BALB/c mice can generate Igh-lb-specific T cells detectable in both
assays, and they support the hypothesis that the B cell is a direct target of allotype-
specific suppression .
* Supported by grants AI-10961, AI-13323, CA-09140, CA-04946, CA-06927, CA-15822, and RR-05539
from the U . S . Public Health Service, grant IN-140 from the American Cancer Society, and by an
appropriation from the Commonwealth of Pennsylvania.
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Materials and Methods
Mice .
￿
Two Igh-congenic strains were used : C.B-17 (Ighb ) and BALB/cAnNIcr (Igh° ) . C.B-
17 refers to BALB/cIcr mice that carry the Igh gene complex ofC57BL/Ka (Ighb ) . C57BL/
6JNIcr, C.B-17, and C57BL/Ka are not known to differ with respect to the Ighb complex . All
mice were bred and maintained at the Institute for Cancer Research .
Cell Lines.
￿
The cell lines used in this study are listed in Table I. CB101, B79, and U10 were
derived from plasmacytomas generously supplied by Dr . Michael Potter (National Cancer
Institute, Bethesda, Md .) . CB101NP is a variant cell line of CB101 that no longer synthesizes
detectable Igh-lb heavy chains. The Igh-lb-producing hybridomas, 540A6 and R3-367, were
derived from the fusion of a BALB/c myeloma (P3 X 63Ag8) with C57BL/6 spleen cells and
were gifts from Dr. Barbara Knowles (The Wistar Institute, Philadelphia, Pa .) and Dr . Theresa
Imanishi-Karl (Massachusetts Institute for Technology, Boston, Mass.), respectively . S10P is an
Igh-4b-producing hybridoma obtained by the fusion of SP2 (16) with C.B-17 spleen cells
according to the technique of Kennett et al . (17) . All cell lines were maintained in vitro and
periodically recloned to maintain a homogeneous phenotype .
Purification of Igh-1b Proteins.
￿
The Ig proteins in ascites fluids of mice bearing the Igh-lb-
producing plasmacytomas, CBPC101 and BEPC79, were precipitated with (NH4)2SO4 (45%
vol:vol), redissolved in 0 .2 M NaCl, and dialyzed extensively against 10 mM NaCl . The
resulting euglobulin precipitate was redissolved in 0.5 M NaCl, 100 mM Tris, pH 8, and
subjected to gel filtration over a column of Biogel A0.5 (Bio-Rad Laboratories, Richmond,
Calif .) equilibrated with the same buffer . The ascending limb of the 7S peak was collected and
concentrated by vacuum dialysis against 150 mM NaCl, 10mM Tris, pH 8 . Purified Igh-1 a,
Igh-4 8
, and Igh-4b myeloma proteins were obtained by similar techniques.
R3-367, an Igh-lb protein that binds (3-nitro-4-hydroxyphenyl)acetyl (NP),' was specifically
purified over NP-affinity columns . These columns were prepared by first substituting Sepharose
4B (Pharmacia Fine Chemicals, Piscataway, N. J.) with amino groups by resuspending CNBr-
activated Sepharose in ethylenediamine (25% vol:vol, pH 9) . NP was subsequently attached by
an overnight incubation at 25°C of the amino-substituted Sepharose (50% vol:vol in 3%
NaHC03, pH 8.5) with an equal volume of dioxane containing NP-cap-succinimide (2.5 mg/
ml ; Biosearch, San Rafael, Calif) (18) . Ascites fluids from mice bearing R3-367 tumors were
allowed to clot, clarified by centrifugation, and then mixed with an equal volume of Alsever's
solution and passed through an NP column . The column was washed with phosphate-buffered
saline (PBS) until the eluate OD was<0.005 . The anti-NP antibodies were then eluted with 5
X 10-4 M (3-nitro-4-hydroxy-5-iodophenyl)acetyl-cap, and dialysed extensively against PBS .
The purity of these preparations was monitored by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis .
Immunizations.
￿
Immunization of BALB/c mice against purified Igh-lb proteins of different
tumors (CBPC101, BEPC79, and R3-367) consisted of multiple intraperitoneal injections of
100 jig of Igh-lb. The first injection was in complete Freund's adjuvant, the second was in
incomplete adjuvant, and subsequent injections were in buffered saline . Hyperimmunization of
BALB/c mice with C57BL/6 serum was done in the manner described earlier (19) .
Igh-1b Suppression.
￿
The ability of immune T cells to induce Igh-lb suppression in vivo was
assessed by a protocol described elsewhere (7) . Briefly, immune BALB/c T cells (2 X 106 ) and
C.B-17 spleen cells (2 X 106 ) were cotransferred (intravenously) into sublethally irradiated (550
rad) BALB/c recipients. Recipient sera were tested in Ouchterlony assays for production of
Igh-l b .
Rosetting ofIg-binding TCells .
￿
Purified myeloma proteins or salt fractionated goat-anti-mouse
Ig (GAMIg) were coupled to sheep erythrocytes (SRBC) by means of CrC13 according to the
procedure of Goding (20) . Briefly, 1 ml of CrC13 (0.01% wt:vol in saline) was slowly added to
a 3-ml vortexing solution ofSRBC (33% vol :vol) and Ig (0.3 mg/ml) . The mixture was allowed
to stand for 10 min at 25°C and washed twice with PBS .
Rosette-forming T cells were prepared and purified as described by Parish and McKenzie
(21) . Nylon wool-purified T cells were spun down with a 100-fold excess ofSRBC, allowed to
Abbreviations used in this paper: GAMIg, goat anti-mouse Ig ; HBSS, Hanks' balanced salt solution ; NP,
(3-nitro-4-hydroxyphenyl)acetyl hapten; PBS, phosphate-buffered saline ; SRBC, sheep erythrocytes ; Tc,
cytotoxicT cells; Ts, suppressor T cells.482
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TABLE I
Tumor Cell Lines
stand 60 min at 25°C, and gently resuspended in 1 ml Hanks' balanced salt solution (HBSS) .
The cell suspension was layered over a solution of Ficoll (5.6%)/Isopaque (9.6%) and spun at
2,000 g for 15 min at 25°C . The cell pellet was washed twice with HBSS, and the SRBC were
lysed with NH4C1 (22).
Generation of Cytotoxic T (Tc) Cells.
￿
Single cell suspensions were prepared from spleens of
immunized mice and the erythrocytes were lysed by treatment with NH4C1. 5 X 106 spleen cells
were cultured with 1 X 105-10 X 105 irradiated (2,000 rad) CB101 cells in a total volume of 2
ml in Linbro tissue culture dishes (Flow Laboratories, Hamden, Conn.). The culture medium
consisted of RPMI-1640 (Microbiological Associates, Walkersville, Md.), 10% fetal calf serum,
5 X 10-5 M 2-mercaptoethanol, 501ag/ml gentamycin (Schering Corp., Kenilworth, N. J.), and
2 mM glutamine. Cultures were incubated at 37°C in a humidified incubator for 5-6 d.
Cytotoxicity Assay.
￿
After 5-6 d in culture, the effector cells were harvested and tested in a
standard 5'Cr release assay (23). In the majority of experiments, the spontaneous release values
were <20% of the maximum release, which was determined by detergent lysis. Experiments in
which the spontaneous release was >35% were discarded. All results are reported as percent
specific lysis, which is calculated as 100 X (EXP - spontaneous release)/(maximum release -
spontaneous release), where EXP equals the counts per minute of chromium released in the
presence of effector cells. All values represent the mean of quadruplicate measurements. In all
cases, the standard errors were <5% and therefore they are not given.
Antiserum and Complement Treatments.
￿
Anti-Thy-1 .2 was prepared in AKR/J mice by multiple
immunizations with C3H/J thymocytes. For T cell depletion, 0.2 ml of this antiserum was
added to 2.5 X 107 cells. After 30 min on ice, the cells were washed twice and resuspended in
2 ml guinea pig serum (1 :7 dilution), as a source of complement, and incubated for 45 min at
37 °C. Under these conditions, >95% of thymocyte and <5% of bone marrow cells are killed.
Results
Evidence for Suppressor T (Ts) Cells Specific for Igh-Ib
(Igh-Ib-specific Ts Cells).
￿
Cell
rosetting techniques were used to evaluate whether BALB/c mice immune to Igh-l b
contained Igh-l b-specific Ts cells. Two rosetting procedures were used. In the first,
nylon wool-purified T cells, derived from BALB/c mice immunized with C57BL/6
serum, were rosetted with SRBC coupled with Igh-lb or Igh-1 a proteins. In the second
procedure, the T cells were first incubated with soluble Igh-l b
or Igh-1a, washed, and
rosetted with SRBC coupled with GAMIg. In both procedures, the rosetting cells
were purified by Ficoll-Isopaque gradients; the SRBC were subsequently lysed with
NH4C1 and the T cells were admixed with C .B-17 spleen cells and injected into
irradiated (550 rad) BALB/c recipients. The results (Table II) demonstrate that all
the mice receiving T cells rosetted with Igh-lb were suppressed for Igh-lb production
at 4 wk (groups A and E), whereas only one out of five recipients was suppressed in
the control groups (groups B-D, F, and G) . These findings indicate that some allotype
Cell line Plasmacytoma Origin Ig product
CB101 CBPC101 C.B-20 16, k
CB101NP - CB101 variant None
B79 BEPC79 CXBE lb, k
U10 UPC10 BALB/c la, k
540A6 - C57BL/6-BALB/c hybridoma l b, 4a, k
R3-367 - C57BL/6-BALB/c hybridoma lb, k, 7t
slop - C.B-17-BALB/c hybridoma 4b, kH. R. SNODGRASS, D. B. WILSON, AND M. J. BOSMA
TABLE 11
Ability of Igh-Ib-rosetted T Cells to Suppress Igh-/b Production
* Nylon wool-purified splenic T cells from BALB/c mice that had been
immunized with C57BL/6 serum were incubated with SRBC to which Ig
had been directly coupled via the CrC13 technique, or alternatively, the T
cells were incubated with soluble Ig, washed, then incubated with SRBC
coupled with a polyspecific (GAMIg). The rosetting cells were purified by
Ficoll-Isopaque gradients.
$The rosette-forming cells from 10 X 106 T cells were admixed with 2 X 106
C.B-17 spleen cells and injected intravenously into irradiated (550 rad)
BALB/c recipients (five animals per group). The presence of Igh-lb was
monitored for up to 10 wk. All animals expressed Igh-4b at 10 wk.
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FIG. 1.
￿
Lysis of CB101 target cells by spleen cells from Igh-lb-immunized BALB/c mice. Spleen
cells from Ig
b-immune or nonimmune BALB/c mice were cultured with or without the myeloma
cells indicated. After 5-6 d, the resulting cells were tested in 5'Cr-release cytotoxicity assays using
CB101 cells as targets.
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Ts cells are specific for the Igh-l b allotype. All recipients expressed Igh-4b at 10 wk
(data not shown) .
Allotype-specific Tc Cells.
￿
Spleen cells from Igb-immune BALB/c mice were restim-
ulated in vitro with an irradiated Igh-lb-producing myeloma, CB101, and then tested
for cytolytic activity against radiolabeled CB101 cells. Fig. 1 illustrates the mean
cytolytic activity from eight such experiments. These experiments demonstrate that
both in vivo priming and in vitro restimulation are required to generate detectable
cytolytic activity. Importantly, CB101NP, a non-Ig-producing variant of CB101, does
not effectively restimulate Tc cell activity.
The cells responsible for the cytolytic effect are T cells; this is demonstrated by the
Number ofanimals positive for
Group Rosetting conditions*
Igh-I b at
cell
various
transfer
times after
(wk)$
2 3 4
A Igh-lb-SRBC 0 0 0
B Igh-18-SRBC 5 5 4
C SRBC 5 5 5
D No T cells 5 5 4
E Igh-Ib + GAMIg-SRBC 1 1 0
F Igh-la + GAMIg-SRBC 5 5 4
G GAMIg-SRBC 5 5 5484
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observation that prior treatment of these killer cell populations with anti-Thy-1.2 and
complement abrogates their lytic ability (Table III) .
Specificity ofthe Tc Cells.
￿
The functional specificity of cytolytic T cells, which were
primed in vivo with C57BL/6 immune serum and restimulated in vitro with CB101
myeloma cells, was assessed by comparing their lytic potency on a variety of different
cell lines. The results show that only Igh-l b-producing cell lines are lysed (Fig. 2) .
Targets that were not lysed included the non-Ig-producing variant of CB 101
(CB101NP), an Igh-la-producing myeloma (U10), an Igh-4b-producing BALB/c X
C.B-17 hybridoma (S10P), as well as C.B-17 mitogen-induced (lipopolysaccharide
and concanavalin A) blast cells.
These data suggest that Tc cells generated in this fashion are specific for determi-
nants of the Igh-lb allotype. The experiments presented in Table IV support this
suggestionby demonstrating that purified Igh-lb can serve as the priming immunogen.
Chromatographically purified Igh-lb myeloma proteins (CB101 and B79) and an
affinity-purified Igh-l b hybridoma protein (R3-367) all efficiently prime the
BALB/c Tc cell response (Table IV) .
Fig. 3 demonstrates that BALB/c anti-Igh-lb Tc display an apparent major
histocompatibility complex restriction; they lyse Igh-lb-producing targets of the
Experiment
TABLE III
Sensitivity ofCytotoxic Activity to Anti-Thy-1.2 andComplement Treatment
Percent specific lysis ofCB101 targets after
treatment of effectors with
Complement
Anti-Thy-1.2 +
complement
1
￿
45
￿
1.2
2
￿
58
￿
2.5
Effectors were generated as described in Materials and Methods from spleen
cells of mice that had been immunized in vivo with C57BL/6 serum, and
restimulated in vitro with CB101 myeloma cells. Before treatment, the effector:
target ratio was 40:1 and no adjustment was made in cell numbers after the
various treatments.
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FIG. 2.
￿
Specificity of BALB/c-anti-Igb Tc cells. The lytic potency of BALB/c Tc cells that were
primed in vivo with C57BL/6 serum and restimulated in vitro with CB101 myeloma cells was
tested on radiolabeled target cells as indicated.H. R. SNODGRASS, D. B. WILSON, AND M. J. BOSMA
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TABLE IV
Ability of Purified Igh-1b to Prime Tc Cells That Lyse CB101 Target Cells
BALB/c Tc cells generated by*
￿
Percent specific lysis of*
* Spleen cells from BALB/c mice that hadbeen immunized as indicated were
cultured either with or without CB101 myeloma cells and tested in "'Cr-
release assays as described in Materials and Methods.
$ Values of specific lysis reported were obtained at effector:target ratio of
40:1.
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￿
Major histocompatibility complex restriction of BALB/c-anti-Igh-ib Tc cells. The lytic
ability of BALB/c (H-2d, Igh-1°) T cells primed with Igh-lb allotype, and restimulated in culture
with the Igh-ló-producin
￿
myeloma, C13101 (H-2d, Igh-16
) were tested on target cells, expressing
Igh-lb and the same (H-2~ or a different (H-2) major histocompatibility complex haplotype.
immunizing H-2°` haplotype but not Igh-lb targets of the B79 line expressing a
different major histocompatibility complex haplotype, H-2b.
Effects of Anti-Igh-lb Tc Populations on Igh-lb Expression In Vivo.
￿
The final series of
experiments explores the possibility that primed and restimulated populations of Igh-
lb-specific Tc are able to suppress expression of Igh-l b proteins in vivo. Table V shows
that BALB/c recipients of target C.B-17 spleen cells and anti-Igh-l b effector Tc
populations fail to express Igh-lb allotype while continuing to express the Igh-4b
allotype.
Discussion
The preceding results provide direct evidence for the existence of allotype-specific
T cells. T cell populations primed in vivo with Igh-lb proteins and restimulated in
vitro with Igh-l b-expressing myeloma cells are able to suppress the production of
In vivo immunization
In vitro
restimulation CB101 CB101 NP
C13101 protein CB101 62 5
None 1 0
B79 protein CB101 55 7
None 3 3
R3-367 protein CB 101 58 5
None 1 1
None CB101 0 2486
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TABLE V
Ability of Tc Cell Populations to Induce Suppression ofIgh-lb Production In Vivo
C.B-17 donor allotypes
Percent specific
￿
present 3-4 wk after
* Primary Tc cells were generated by restimulating Igh-l 6-immunized BALB/c spleen
cells with CB 101 myelomacells in vitro for 5 d.
Effector:target ratios were 50 :1 for the primary Tc cells.
§5 X 106 primary Tc cells or normal lymph node cells were cotransferred with 5 X
106 C.B-17 spleen cells into irradiated (550 rod) BALB/c recipients. The presence
of C.B-17 allotypes was monitored weekly. The values represent the number of
animals expressing the indicated allotype over the total number of animals in the
group.
Igh-l
b proteins in vivo, and they are also specifically lytic for target cells expressing
Igh-l b proteins.
Earlier studies in mice have shown that chronic suppression of Igh-lb production is
mediated by T cells (5, 7). These studies concluded that the target of Ts was a helper
T cell population, and from this it seems unlikely that the specificity of Ts would be
directed to an Ig allotype.
To investigate this point, the specificity of a Ts cell population capable of regulating
allotype expression was examined by using rosetting procedures. Table II illustrates
that Ts cells can be demonstrated with two different procedures to bind Igh-l"
specifically. T cells that form rosettes with Igh-l b-coupled SRBC are active in
suppressing expression of Igh-lb in vivo, whereas the cells that rosette with Igh-1a are
not. In addition, Ts cells that bind soluble Igh-l b with sufficient affinity to be rosetted
by anti-Ig-coated SRBC are also capable of suppressing Igh-lb in vivo. There are
currently many examples in the literature of antigen-binding Ts cells (24-28);
therefore the finding that allotype Ts cells bind Igh-lb is not without precedent.
It is of interest that the nonrosetted immune BALB/c spleen cell population was
also capable of Igh-lb suppression in vivo (unpublished results) . This could result
either from a technical shortcoming, i.e., that rosetting was incomplete, or alterna-
tively, immune spleen cell populations may contain allotype suppressor T cells with
specificity directed to determinants other than the Igh-l b allotype itself.
The most straightforward interpretation of the results of the Igh-l" rosetting
experiments is that Ts exist having surface receptors specific for Igh-lb and that
interaction of these cells with target Igh-lb B cells results in their suppression or
elimination. This interpretation is supported by the demonstration in earlier studies
that Igh-lb myelomas fail to grow in allotype-suppressed hosts (13) .
Specificity of Tc Cells from Igh-lb-immune BALB/c Mice.
￿
The studies described here
also show that priming BALB/c mice with C57BL immune serum in vivo and
restimulation with Igh-lb myeloma in vitro induces cytotoxic T cells that lyse Igh-l
b-
producing myelomas (Figs. 1 and 2) . Several findings support the conclusion that
these Tc cells' are specific for allotypic determinants present on the Igh-lb molecule:
(a) in vivo priming is required for generating cytotoxic cells and this can be
Experiment T cell population* lysis of CB 101
targets
Igh-In
cotransfer§
Igh-46
1 Primary 60 0/8 8/8
2 Primary 53 0/5 5/5
3 Normal 2 5/5 5/5H . R . SNODGRASS, D . B . WILSON, AND M . J . BOSMA
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accomplished with purified Igh-lb myeloma proteins (Table IV) ; (b) restimulation in
vitro is also required and only Igh-lb-producing myelomas are effective stimulators ;
a nonproducing variant is not effective (Fig. 1) ; (c) once stimulated, these cytotoxic
cells are lytic only for Igh-lb-producing target cells. Target cells not lysed include
Igh-1a- and Igh-4b-producing cell lines as well as an Ig-non-producing variant of
CB101, CB101NP (Fig. 2), which does not secrete or produce any detectable Igh-l"
(unpublished results) ; and (d) idiotypes are apparently not involved because two
independent Igh-l b-producing cells can serve as targets (Fig . 2) and three different
myeloma proteins can serve as priming immunogens for this Tc response (Table IV) .
Tumor-specific antigens in these experiments can be ruled out by the observation
that affinity-purified Ig can serve as the priming immunogen (Table IV), and by the
finding that CB101NP is not lysed (Fig . 2) . The involvement of allotype-linked minor
histocompatibility differences between BALB/c and C.B-17 mice (29-31) can also be
excluded . These antigens are expressed on mitogen-induced blasts, and would also be
expected to be present on an Igh-4b-producing hybridoma cell line that is partly of
C.B-17 origin . Nevertheless, these particular target cells are not lysed by allotype-
primed killer cells (Fig . 2) .
The strongest evidence supporting the conclusion that these Tc are specific for
allotypic determinants of the Igh-lb molecule is presented in the accompanying paper
(32) . Tc cells cloned from bulk populations similar to those described in Fig. 2 display
functional specificity identical with the bulk populations . Incubation of these cloned
Tc cells with affinity-purified Igh-lb results in a marked and specific reduction of the
cytotoxic ability of these cells .
Another important aspect of killer cell specificity is that controlled by gene products
of the major histocompatibility complex . Preliminary results indicate that allotype-
specific cytotoxic populations are restricted to the BALB/c (H-2d) haplotype . These
studies are limited, however, because target cell lines expressing Igh-lb and major
histocompatibility complex haplotypes other than H-2d are not available .
Involvement of Tc Cells in Allotype Suppression .
￿
Because both T cell effector functions,
suppression and cytotoxicity, seem to be mediated by T cells of like specificity for
determinants of the Igh-l b molecule, the question arises whether both functions are
mediated by the same T cell . The present studies indicate that at the level of bulk
populations of effector cells, these two functions cannot be separated . Both can be
inducedby priming with purified Igh-lb proteins and both show specificity for Igh-lb
proteins, one by rosetting and the other by cytotoxicity . Moreover, as described in the
accompanying paper, a cytotoxic Igh-lb-specific T cell line is able to suppress
expression of Igh-l b in vivo (32) . We therefore feel that the possibility remains that
allotype-specific Tc could have a physiologic role in the regulation of allotype
suppression .
Another precedent for the suggestion that Tc may regulate expression of Ig in vivo
is the demonstration of Segal et al . (33) that T cells from high zone tolerant mice
could kill macrophages pulsed with the tolerizing antigen . However, Abbas et al . (34-
36) have shown recently that suppression and cytotoxicity may operate by quite
different mechanisms at the level of the target cell . Tc directed against one of the Ig
proteins of a double producing hyridoma caused the cessation of synthesis of both Ig
proteins and target cell lysis, but when exposed to Ts cells specific for one of the Ig488
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proteins, synthesis of only the specific protein was suppressed in the double producing
hybridoma.
The premise that B cells are the direct target of Ts cells in chronic allotype
suppression stands in apparent contrast to mechanisms suggested by Herzenberg et
al. (14). In this model, Ts cells are thought to eliminate Igh-lb-specific Th cells and
thereby to influence Igh-lb production indirectly. The target determinants of helper
T cells that provide the basis for discrimination by Ts cells have not been identified.
In our view, these mechanisms are not necessarily mutually exclusive; both could be
operative to varying degrees. Consistent with this suggestion is the recent observation,
using the neonatal suppression system where helper T cells are thought to be the
target of Ts cells, of the existence of Ts cells that inhibit both T-independent Igh-lb
production (37) and the growth of an Igh-l b myeloma (38) .
It remains unclear in the neonatal suppression system how administration of anti-
allotype antibody induces allotype-specific Ts cells. One possibility that could be
considered is that the temporary elimination of allotype-producing B cell subpopu-
lations by anti-allotype antibody results in the consequent lack of tolerance in the T
cell compartment to Ig allotyppc determinants. The later emergence of allotype-
positive B cells could then induce activation of allotype-specific T suppressor and/or
killer cells. Similarly, in the absence of allotype-positive B cells, one might expect
alterations in the expressed repertoire of T cells having specificity for allotype (39).
Summary
We show that determinants of IgG2a of C57BL/6 mice (Igh-l b) stimulate allotype-
specific T cells in BALB/c mice. Such cells are detected in two different functional
assays; chronic allotype suppression and T cell-mediated cytotoxicity. A population
of suppressorT cellscapable of inducing chronic Igh-l b suppression was demonstrated
by rosetting procedures to possess Igh-lb-specific receptors, a result interpreted as
indicating that suppressor T cells may act directly upon allotype-bearing B cells.
From similar populations we were also able to demonstrate Igh-l b-specific cytotoxic
T cells. Such cells were lytic for target myeloma cells expressing the Igh-lb allotype of
IgG28, and were ineffective against a variant cell line failing to express Igh-l b, and
other target cell lines expressing different allotypes or isotypes. The similar specificity
of suppressor T cells and cytotoxic T lymphocytes for Igh-lb allotype raises the
possibility that the target in allotype suppression is a B cell, and that allotype-specific
cytotoxic T cells may play some role in regulation of allotype expression in the
suppressed state.
Receivedforpublication 20 April 1981.
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